Navigation Links
SweetSpot Diabetes Care Receives FDA 510(k) Clearance for SweetSpot Diabetes Data Management Service
Date:11/29/2011

PORTLAND, Ore., Nov. 29, 2011 /PRNewswire/ -- SweetSpot Diabetes Care, Inc. announced today it has received 510(k) clearance from the United States Food & Drug Administration (FDA) for the SweetSpot Diabetes Data Management Service which helps health care providers and patients see, understand and use blood glucose meter data to diagnose and manage diabetes.

"We spoke to many patients and health care providers to develop this service," said Christopher Logan, Chief Executive Officer of SweetSpot Diabetes Care, Inc.  "Patients want something that works with all their devices that's as easy as an ATM. Health care providers want technology sophisticated enough that it's almost invisible - reports show up where and when they are needed and the data flow is fully automated. With the SweetSpot Diabetes Data Management Service more clinics will gain the benefit of comprehensive analysis of patient blood glucose data. We are thrilled to be cleared to market this to clinics."

The SweetSpot Diabetes Data Management Service automates the workflow of blood glucose data from device retrieval through data processing, analysis, report generation and delivery into clinical settings and electronic records. A cloud-based platform is the backbone - enabling secure interactions with all formats of patient devices and communications with all sites in the evolving diabetes care setting landscape.

Vendor-Neutral Device Retrieval

Data from most common blood glucose meters can be retrieved during a step-by-step session at a physical kiosk or through a web-based application. Patient information and clinical history may be collected at the same time. For patients with multiple glucometers, data from all devices will be merged into one set.

Backend Processing and Analytics

The SweetSpot Diabetes Data Management Service performs multiple data processing steps - checking the validity and completeness of data from devices. Various analyses are run when data is saved or updated within the system including time-series statistical analysis and pattern-recognition. Cohort analysis is also undertaken, looking at groupings and relationships such as gender, age, diabetes type, etc.

Immediate Report Generation and Delivery

As soon as patient glucose data is retrieved, the SweetSpot Diabetes Data Management Service generates a report and pushes it straight to clinic printers and/or electronic health record systems. Patients can also receive reports via a secure link.

Comprehensive Visualizations of Critical Data

Reports contain visualizations of daily and weekly glucose levels; display testing frequency; and provide statistical summaries and measures of glucose variability.

Reports may also compare a patient's data with their cohort and can be customized by a clinic to best support their providers and patients.

"Blood glucose data is important for effective diabetes management," said Adam Greene, SweetSpot Founder and Chief Technology Officer.  "We are excited to offer a service that makes it practical for any clinic to access their patients' data and use that information to improve care."

About SweetSpot Diabetes

SweetSpot Diabetes is a health data company focused on improving the use of data in the treatment of diabetes. SweetSpot specializes in turning raw output from patient devices into powerful information for researchers, health care providers and patients.

For more information, go to http://www.sweetspotdiabetes.com

Contact:   Cheryl Vandemore (503) 708-6654


'/>"/>
SOURCE SweetSpot Diabetes Care, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SweetSpot Diabetes Care, Inc. Registers SweetSpot Data Transfer Service as a Medical Device Data System (MDDS) With FDA
2. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
3. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
4. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
5. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
6. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
7. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
8. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
9. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
10. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
11. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... for the National Institute for Health and Care Excellence (NICE) framework. ... the National Health Service (NHS) to search, order and purchase medical and healthcare-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a ... today announced that Premier Research, a leading clinical development service provider, has selected ... becoming increasingly complex, due in part to an array of circumstances including the ...
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... HealthPostures, the desk ... an expert sit stand solutions representative to the Minneapolis Home and Garden Show which ... the event that is garnering national attention is the Minneapolis Convention Center. , ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane society demands higher ... sharpest brain. , Power On, a mental performance enhancer from Modus Nutrition, provides ... Each capsule contains Cognizin® Citicoline, a branded form of the brain health nutrient ...
Breaking Medicine News(10 mins):